Rein Therapeutics, Inc. announced a $1 million Pre-Paid Advance from Yorkville on October 23, 2025, with total advances reaching $6 million over 12 months, subject to terms. The company has issued 1,880,872 shares to offset advances totaling over $2 million since July 2025.